Literature DB >> 12681166

[Review of plasma anti-aggregants and their indications in primary care. Eight years later].

M Blasco Valle1, J F Lucía Cuesta.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12681166      PMCID： PMC7679698          DOI： 10.1016/s0212-6567(03)79168-9

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  61 in total

1.  Conservative management of intermittent claudication.

Authors:  K Radack; R J Wyderski
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391

2.  Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group.

Authors:  F Balsano; P Rizzon; F Violi; D Scrutinio; C Cimminiello; F Aguglia; C Pasotti; G Rudelli
Journal:  Circulation       Date:  1990-07       Impact factor: 29.690

3.  Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits.

Authors:  G Defreyn; C Gachet; P Savi; F Driot; J P Cazenave; J P Maffrand
Journal:  Thromb Haemost       Date:  1991-02-12       Impact factor: 5.249

4.  Mitral valve disease, systemic embolism and anticoagulants.

Authors:  H A Fleming; S M Bailey
Journal:  Postgrad Med J       Date:  1971-09       Impact factor: 2.401

5.  Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1991-11-30       Impact factor: 79.321

Review 6.  [Platelet antiaggregants: a review of their indications in primary care].

Authors:  M Blasco Valle; A Vitoria Lapeña; E Robledo
Journal:  Aten Primaria       Date:  1993-02-28       Impact factor: 1.137

7.  The Anturane Reinfarction Trial: reevaluation of outcome.

Authors: 
Journal:  N Engl J Med       Date:  1982-04-22       Impact factor: 91.245

8.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

9.  Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial.

Authors:  D L Dawson; B S Cutler; M H Meissner; D E Strandness
Journal:  Circulation       Date:  1998-08-18       Impact factor: 29.690

10.  Randomised trial of prophylactic daily aspirin in British male doctors.

Authors:  R Peto; R Gray; R Collins; K Wheatley; C Hennekens; K Jamrozik; C Warlow; B Hafner; E Thompson; S Norton
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.